Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Chunrun Qu, Hao Zhang, Hui Cao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 277
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
Jian-Wen Fang, Yue Lu, Jingyan Zheng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 73
Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating
Mohamad Hamieh, Jorge Mansilla‐Soto, Isabelle Rivière, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 829-843
Open Access | Times Cited: 64
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 63
CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression
Andrew S. Luksik, Eli Yazigi, Pavan P. Shah, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1414-1414
Open Access | Times Cited: 47
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
Lusine Hovhannisyan, Carsten Riether, Daniel M. Aebersold, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Yalan Zhang, Weilin Zhou, Jianping Yang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Xiaoxia Chi, Shahang Luo, Peng Ye, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies
Yuxian Huang, Yinjie Qin, Yingzhi He, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101082-101082
Open Access | Times Cited: 12
Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies
Xiaoye Shi, Gengwen Deng, Huifang Wen, et al.
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 9
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
A performance evaluation of drug response prediction models for individual drugs
Aron Park, Yeeun Lee, Seungyoon Nam
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer
Yu Cao, Sergey Efetov, Mingze He, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Closed Access | Times Cited: 13
Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy
Maryam Sahlolbei, Amirhossein Ahmadieh-Yazdi, Mohadeseh Rostamipoor, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 5
Exploring CAR-macrophages in non-tumor diseases: Therapeutic potential beyond cancer
Yizhao Chen, Qianling Xin, Mengjuan Zhu, et al.
Journal of Advanced Research (2025)
Open Access
Epigenetic Perspective of Immunotherapy for Cancers
Sunita Keshari, Praveen Barrodia, Anand K. Singh
Cells (2023) Vol. 12, Iss. 3, pp. 365-365
Open Access | Times Cited: 12
Advances in research on immune escape mechanism of glioma
Xu Guo, Gang Wang
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 1709-1720
Open Access | Times Cited: 11
Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis
Dovydas Gečys, Rūta Skredėnienė, Emilija Gečytė, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1247-1247
Open Access | Times Cited: 11
CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors
Yonggui Tian, Liubo Zhang, Yu P, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
The potential role of the thymus in immunotherapies for acute myeloid leukemia
Christopher Hino, Yi Xu, Jeffrey Xiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Targeted therapy for rare lung cancers: Status, challenges, and prospects
Chunsen Wang, Xiang Yuan, Jianxin Xue
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1960-1978
Open Access | Times Cited: 10
Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma
Pornpimon Yuti, Nunghathai Sawasdee, Krissada Natungnuy, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115691-115691
Open Access | Times Cited: 10
Novel CAR‐T Cells Specifically Targeting SIA‐CIgG Demonstrate Effective Antitumor Efficacy in Bladder Cancer
Mengting Ding, Jiaxing Lin, Caipeng Qin, et al.
Advanced Science (2024) Vol. 11, Iss. 40
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top